Innate immunity and the role of epithelial barrier during Aspergillus fumigatus infection

Current Immunology Reviews

Volumn 8, Issue 3, 2012, Pages 254-261

  Svirshchevskaya, Elena ^a   Zubkov, Dmitrii ^a   Mouyna, Isabelle ^b   Berkova, Nadia ^c  

^a SHEMYAKIN OVCHINNIKOV INSTITUTE OF BIOORGANIC CHEMISTRY   (Russian Federation)

^b INSTITUT PASTEUR   (France)

^c AGROCAMPUS OUEST   (France)

Author keywords

Aspergillosis; Aspergillus fumigatus; Dectin 1; Defensin; Epithelial cells; Fikolin 2; Genetic factors

Indexed keywords

ALPHA INTERFERON; BETA DEFENSIN; C TYPE LECTIN LIKE RECEPTOR; C TYPE LECTIN RECEPTOR; DECTIN 1; DECTIN 2; FICOLIN; FICOLIN 1; FICOLIN 2; FICOLIN 3; FUNGAL ENZYME; IMMUNOGLOBULIN A; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; LECTIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN; MANNOSE BINDING LECTIN; MONOCYTE CHEMOTACTIC PROTEIN; PATTERN RECOGNITION RECEPTOR; PENTRAXIN 3; SERINE PROTEINASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C; SURFACTANT PROTEIN D; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANTIFUNGAL ACTIVITY; APOPTOSIS; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CELL INVASION; CELLULAR IMMUNITY; EPITHELIAL BARRIER; EPITHELIUM CELL; FUNGUS IMMUNITY; HUMAN; HUMORAL IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INFECTION CONTROL; INNATE IMMUNITY; LUNG ALVEOLUS MACROPHAGE; MUCOSA; NEUTROPHIL; NONHUMAN; PATTERN RECOGNITION; PERMEABILITY BARRIER; PRIORITY JOURNAL; RESIDENT ALVEOLAR MACROPHAGE; RESPIRATORY EPITHELIUM;

EID: 84861730464     PISSN: 15733955     EISSN: 1875631X     Source Type: Journal    
DOI: 10.2174/157339512800671985     Document Type: Article

References (89)

1. Alekseeva L, Huet D, Féménia F, et al. Inducible expression of beta defensins by human respiratory epithelial cells exposed to Aspergillus fumigatus organisms. BMC Microbiol 2009; 9: 33-40.
2. Kauffman HF, Tomee JF, van de Riet MA, et al. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol 2007; 148: 382-9.
3. Monod M, Jaton-Ogay K, Reichard U. Aspergillus fumigatussecreted proteases as antigenic molecules and virulence factors. Contrib Microbiol 1999; 2: 182-92.
4. Iadarola P, Lungarella G, Martorana PA, et al. Lung injury and degradation of extracellular matrix components by Aspergillus fumigatus serine proteinase. Exp Lung Res 1998; 24: 233-51.
5. Tomee JF, Wierenga AT, Hiemstra PS, Kauffman HK. Proteases from Aspergillus fumigatus induce release of proinflammatory cytokines and cell detachment in airway epithelial cell lines. J Infect Dis 1997; 176: 300-3.
6. Kurup VP, Xia JQ, Crameri R, Rickaby DA, Choi HY, Flückiger S, Blaser K, Dawson CA, Kelly KJ. Purified recombinant A. fumigatus allergens induce different responses in mice. Clin Immunol 2001; 98: 327-36.
7. Berkova N, Lair-Fulleringer S, Féménia F, et al. Aspergillus fumigatus conidia inhibit tumour necrosis factor-or staurosporineinduced apoptosis in epithelial cells. Int Immunol 2006; 18: 139-50.
8. Féménia F, Huet D, Lair-Fulleringer S, et al. Effects of conidia of various Aspergillus species on apoptosis of human pneumocytes and bronchial epithelial cells. Mycopathologia 2009; 67: 249-62.
9. Zelensky AN, Gready JE. C-type lectin-like domains in Fugu rubripes. BMC Genomics 2004; 5: 51-9.
10. Madan T, Eggleton P, Kishore U, et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997; 65: 3171-9.
11. Crouch EC. Collectins and pulmonary defense. Am J Respir Cell Mol Biol 1998; 19: 177-201.
12. Goldman RC, Branstrom A. Targeting cell wall synthesis and assembly in microbes: similarities and contrasts between bacteria and fungi. Curr Pharm Des 1999; 5: 473-501.
13. Luther K, Torosantucci A, Brakhage AA, Heesemann J, Ebel F. Phagocytosis of Aspergillus fumigatus conidia by murine macrophages involves recognition by the dectin-1 beta-glucan receptor and Toll-like receptor 2. Cell Microbiol 2007; 9: 368-81.
14. Korfhagen TR, Bruno MD, Ross GF, et al. Altered surfactant function and structure in SP-A gene targeted mice. Proc Natl Acad Sci U S A 1996; 93: 9594-9.
15. LeVine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 1999; 103: 1015-21.
16. LeVine AM, Hartshorn K, Elliott J, Whitsett J, Korfhagen T. Absence of SP-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 2002; 282: 563-72.
17. Linke MJ, Harris CE, Korfhagen TR, et al. Immunosuppressed surfactant protein A-deficient mice have increased susceptibility to Pneumocystis carinii infection. J Infect Dis 2001; 183: 943-52.
18. Li G, Siddiqui J, Hendry M, et al. Surfactant protein-A--deficient mice display an exaggerated early inflammatory response to a betaresistant strain of influenza A virus. Am J Respir Cell Mol Biol 2002; 26: 277-82.
19. Madan T, Reid KB, Singh M, Sarma PU, Kishore U. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SPD gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigatus. J Immunol 2005; 174: 6943-54.
20. Madan T, Reid KB, Clark H, et al. Susceptibility of mice genetically deficient in SP-A or SP-D gene to invasive pulmonary aspergillosis. Mol Immunol 2010; 47: 1923-30.
21. Erpenbeck VJ, Ziegert M, Cavalet-Blanco D, et al. Surfactant protein D inhibits early airway response in Aspergillus fumigatussensitized mice. Clin Exp Allergy 2006; 36: 930-40.
22. Madan T, Kishore U, Singh M, et al. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 2001; 69: 2728-31.
23. Atochina EN, Beers MF, Tomer Y, et al. Attenuated allergic airway hyperresponsiveness in C57BL/6 mice is associated with enhanced surfactant protein (SP)-D production following allergic sensitization. Respir Res 2003; 4: 15.
24. Botas C, Poulain F, Akiyama J, et al. Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. Proc Natl Acad Sci U S A 1998; 95: 11869-74.
25. Wert SE, Yoshida M, LeVine AM, et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci U S A 2000; 97: 5972-7.
26. Atochina EN, Beck JM, Preston AM, et al. Enhanced lung injury and delayed clearance of Pneumocystis carinii in surfactant protein A-deficient mice: attenuation of cytokine responses and reactive oxygen-nitrogen species. Infect Immun 2004; 72: 6002-11.
27. LeVine AM, Elliott J, Whitsett JA, et al. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 2004; 31: 193-9.
28. Haczku A, Atochina EN, Tomer Y, et al. Aspergillus fumigatusinduced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol 2001; 25: 45-50.
29. Puthothu B, Forster J, Heinze J, Heinzmann A, Krueger M. Surfactant protein polymorphisms are associated with severe respiratory syncytial virus infection, but not with asthma. BMC Pulm Med 2007; 7: 6-15.
30. Cameron HS, Somaschini M, Carrera P, et al. A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr2005; 146: 370-5.
31. Yang L, Johansson J, Ridsdale R, et al. Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH. J Immunol 2010; 184: 975-83.
32. Kaur S, Gupta VK, Thiel S, Sarma PU, Madan T. Protective role of mannan-binding lectin in a murine model of invasive pulmonary aspergillosis. Clin Exp Immunol 2007; 148: 382-9.
33. Crosdale DJ, Poulton KV, Ollier WE, Thomson W, Denning DW. Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis. J Infect Dis 2001; 184: 653-6.
34. Vaid M, Kaur S, Sambatakou H, et al. Distinct alleles of mannosebinding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis. Clin Chem Lab Med 2007; 45: 183-6.
35. Clemons KV, Martinez M, Tong AJ, Stevens DA. Resistance of MBL gene-knockout mice to experimental systemic aspergillosis. Immunol Lett 2010; 128: 105-7.
36. Runza VL, Schwaeble W, Männel DN. Ficolins: novel pattern recognition molecules of the innate immune response. Immunobiology 2008; 213: 297-306.
37. Ma YG, Cho MY, Zhao M, et al. Human mannose-binding lectin and L-ficolin function as specific pattern recognition proteins in the lectin activation pathway of complement. J Biol Chem 2004; 279: 25307-12.
38. Liu Y, Endo Y, Iwaki D, et al. Human M-ficolin is a secretory protein that activates the lectin complement pathway. J Immunol 2005; 175: 3150-6.
39. Moalli F, Doni A, Deban L, et al. Role of complement and Fc{gamma} receptors in the protective activity of the long pentraxin PTX3 against Aspergillus fumigatus. Blood 2010; 116: 5170-80.
40. Jaillon S, Peri G, Delneste Y, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med 2007; 204: 793-804.
41. Ma YJ, Doni A, Hummelshøj T, et al. Synergy between ficolin-2 and pentraxin 3 boosts innate immune recognition and complement deposition. J Biol Chem 2009; 284: 28263-75.
42. Cunningham-Rundles C. Physiology of IgA and IgA deficiency. J Clin Immunol 2001; 21: 303-9.
43. Brummer E, Stevens DA. Collectins and fungal pathogens: roles of surfactant proteins and mannose binding lectin in host resistance. Med Mycol 2010; 48: 16-28.
44. Kishore U, Greenhough TJ, Waters P, et al. Surfactant proteins SPA and SP-D: structure, function and receptors. Mol Immunol 2006; 43: 1293-315.
45. Kuroki Y, Takahashi M, Nishitani C. Pulmonary collectins in innate immunity of the lung. Cell Microbiol 2007; 9: 1871-9.
46. Philippe B, Ibrahim-Granet O, Prevost MC, et al. Killing of Aspergillus fumigatus by alveolar macrophages is mediated by reactive oxidant intermediates. Infect Immun 2003; 71: 3034-42.
47. Ibrahim-Granet O, Philippe B, Boleti H, et al. Phagocytosis and intracellular fate of Aspergillus fumigatus conidia in alveolar macrophages. Infect Immun 2003; 71: 891-903.
48. Taylor PR, Brown GD, Geldhof AB, Martinez-Pomares L, Gordon S. Pattern recognition receptors and differentiation antigens define murine myeloid cell heterogeneity ex vivo. Eur J Immunol 2003; 33: 2090-7.
49. Hope WW, Petraitis V, Petraitiene R, Aghamolla T, Bacher J, Walsh TJ. The initial 96 hours of invasive pulmonary aspergillosis: histopathology, comparative kinetics of galactomannan and (1->3)-d-glucan and consequences of delayed antifungal therapy. Antimicrob Agents Chemother 2010; 54: 4879-86.
50. Sano H, Chiba H, Iwaki D, et al. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 2000; 275: 22442-51.
51. Kamberi M, Brummer E, Stevens DA. Regulation of bronchoalveolar macrophages proinfl ammatory cytokine production by dexamethasone and granulocyte-macrophage colony stimulating factor after stimulation by Aspergillus conidida or lipopolysaccarhide. Cytokine 2002; 19: 14-20.
52. Balloy V, Si-Tahar M, Takeuchi O, et al. Involvement of toll-like receptor 2 in experimental invasive pulmonary aspergillosis. Infect Immun 2005; 73: 5420-5.
53. Bellocchio S, Montagnoli C, Bozza S, et al. The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 2004; 172: 3059-69.
54. Chignard M, Balloy V, Sallenave JM, Si-Tahar M. Role of Tolllike receptors in lung innate defense against invasive aspergillosis. Distinct impact in immunocompetent and immunocompromized hosts. Clin Immunol 2007; 124: 238-43.
55. Netea MG, Ferwerda G, van der Graaf CA, Van der Meer JW, Kullberg BJ. Recognition of fungal pathogens by toll-like receptors. Curr Pharm Des 2006; 12: 4195-201.
56. Bretz C, Gersuk G, Knoblaugh S, et al. MyD88 signaling contributes to early pulmonary responses to aspergillus fumigatus. Infect Immun 2008; 76: 952-8.
57. Mezger M, Kneitz S, Wozniok I, Kurzai O, Einsele H, Loeffler J. Proinflammatory response of immature human dendritic cells is mediated by dectin-1 after exposure to Aspergillus fumigatus germ tubes. J Infect Dis 2008; 197: 924-31.
58. Kerrigan AM, Brown GD. C-type lectins and phagocytosis. Immunobiology 2009; 214: 562-75.
59. Steele C, Rapaka RR, Metz A, et al. The beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatus. PLoS Pathog 2005; 1: e42.
60. Werner JL, Metz AE, Horn D, et al. Requisite role for the dectin-1 beta-glucan receptor in pulmonary defense against Aspergillus fumigatus. J Immunol. 2009; 182(8): 4938-46.
61. Leal SM Jr, Cowden S, Hsia YC, Ghannoum MA, Momany M, Pearlman E. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog 2010; 6: e1000976.
62. Barrett NA, Maekawa A, Rahman OM, Austen KF, Kanaoka Y. Dectin-2 recognition of house dust mite triggers cysteinyl leukotriene generation by dendritic cells. J Immunol 2009; 182: 1119-28.
63. Svirshchevskaya EV, Shevchenko MA, Huet D, et al. Susceptibility of mice to invasive aspergillosis correlates with delayed cell influx into the lungs. Int J Immunogenet 2009; 36: 289-99.
64. Mambula SS, Sau K, Henneke P, Golenbock DT, Levitz SM. Tolllike receptor (TLR) signaling in response to Aspergillus fumigatus. J Biol Chem 2002; 277: 39320-6.
65. Netea MG, Warris A, Van der Meer JWM, et al. Aspergillus fumigatus evades immune recognition during germination through loss of TLR4-mediated signal transduction. J Infect Dis 2003; 188: 320-6.
66. Meier A, Kirschning CJ, Nikolaus T, Wagner H, Heesemann J, Ebel F. Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages. Cell Microbiol 2003; 5: 561-70.
67. Braedel S, Radsak M, Einsele H, Latge J-P, Michan A, Loeffler J, Haddad Z, Grigoleit U, Schild H, Hebart H. Aspergillus fumigatus antigens activate innate immune cells via Toll-like receptors 2 and 4. Br J Haematol 2004; 125: 392-9.
68. Bals R: Epithelial antimicrobial peptides in host defense against infection. Respir Res 2000; 1: 141-50.
69. Evans SE, Scott BL, Clement CG, et al. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am J Respir Cell Mol Biol 2010; 42: 40-50.
70. Phadke AP, Akangire G, Park SJ, Lira SA, Mehrad B. The role of CC chemokine receptor 6 in host defense in a model of invasive pulmonary aspergillosis. Am J Respir Crit Care Med 2007; 175: 1165-72.
71. Ganz T, Weiss T. Antimicrobial peptides of phagocytes and epithelia. Semin Hematol 1997; 34: 343-54.
72. García JR, Jaumann F, Schulz S, et al. Bals: Identification of a novel, multifunctional beta-defensin (human beta-defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res 2001; 306: 257-64.
73. Jia HP, Schutte BC, Schudy A, et al. Discovery of new human beta-defensins using a genomics-based approach. Gene 2001; 263: 211-8.
74. Schutte BC, Mitros JP, Bartlett JA, et al. Discovery of five conserved beta-defensin gene clusters using a computational search strategy. Proc Natl Acad Sci USA 2002; 99: 2129-33.
75. Kao CY, Chen Y, Zhao YH, Wu R. ORFeome-based search of airway epithelial cell-specific novel human (beta)-defensin genes. Am J Respir Cell Mol Biol 2003; 29: 71-80.
76. Bensch KW, Raida M, Mägert HJ, Schulz-Knappe P, Forssmann WG: hBD-1: a novel beta-defensin from human plasma. FEBS Lett 1995; 368: 331-5.
77. Zhao C, Wang I, Lehrer RI: Widespread expression of betadefensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett 2005; 396: 319-22.
78. Harder J, Bartels J, Christophers E, Schröder JM. A peptide antibiotic from human skin. Nature 1997; 387: 861-5.
79. Schröder JM, Harder J: Human beta-defensin-2. Int J Biochem Cell Biol 1999; 31: 645-51.
80. Weinberg A, Krisanaprakornkit S, Dale BA. Epithelial antimicrobial peptides: review and significance for oral applications. Crit Rev Oral Biol Med 1998; 9: 399-414.
81. Levitz SM, Selsted ME, Ganz T, Lehrer RI. Diamond RD: In vitro killing of spores and hyphae of Aspergillus fumigatus and Rhizopus oryzae by rabbit neutrophil cationic peptides and bronchoalveolar macrophages. J Infect Dis 1986; 154: 483-9.
82. Okamoto T, Toyohiro T, Wei B, Ueta E, Yamamoto T, Osaki T. Regulation of Fungal Infection by a Combination of Amphotericin B and Peptide 2, a Lactoferrin Peptide That Activates Neutrophils. Clin Diagn Lab Immunol 2004, 11: 1111-9.
83. Simon A, Kullberg BJ, Tripet B, et al. Drosomycin-like defensin, a human homologue of Drosophila melanogaster drosomycin with antifungal activity. Antimicrob Agents Chemother 2008; 52: 1407-12.
84. Funderburg N, Lederman MM, Feng Z, et al. Human defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc Natl Acad Sci USA 2007; 104: 18631-5.
85. Soruri A, Grigat J, Forssmann U, Riggert J, Zwirner J. Beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved. Eur J Immunol 2007; 37: 2474-86.
86. Krarup A, Thiel S, Hansen A, Fujita T, Jensenius JC. L-ficolin is a pattern recognition molecule specific for acetyl groups. J Biol Chem 2004; 279: 47513-9.
87. Bourke E, Bosisio D, Golay J, Polentarutti N, Mantovani A. The toll-like receptor repertoire of human B lymphocytes: inducible and selective expression of TLR9 and TLR10 in normal and transformed cells. Blood 2003; 102: 956-63.
88. Muzio M, Polentarutti N, Bosisio D, Prahladan MK, Mantovani A. Toll-like receptors: a growing family of immune receptors that are differentially expressed and regulated by different leukocytes. J Leukoc Biol 2000; 67: 450-6.
89. Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsdörfer B, Giese T, Endres S, Hartmann G. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 2002; 168: 4531-7.